DEPO Financial Facts

Total selling, general and administrative expense: 51.57M
Research and development expense: 10.41M
See Full Income Statement

Common stock, no par value: 283.9M
Receivables from collaborative partners: 427K
See Full Balance Sheet

(DEPO) Earnings

  |   Expand Research on DEPO
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate N/A Revenue Growth Rate N/A
Average % Move 1-Wk after EPS N/A Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details